14th Sep 2005 11:52
Smith & Nephew Plc14 September 2005 Smith & Nephew Orthopaedics Announces Change to Investor Visit Webcast Timing 14 September 2005 Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical technologybusiness, will be holding a visit for institutional investors and analysts atthe global headquarters of the company's orthopaedics business in Memphis,Tennessee, on Thursday 15 September 2005. The main presentations of the event will be webcast live on Smith & Nephew'scorporate website at www.smith-nephew.com and will begin at 1:30pm BST/8:30amEST/7:30am CST on Thursday 15 September 2005. An archive of these presentationswill be available on the site shortly after the close. The visit will be hosted by Chief Executive, Sir Christopher O'Donnell, and DaveIllingworth, President of Smith & Nephew Orthopaedics. During the visit guestswill have the opportunity to meet senior management, visit the manufacturingfacilities and receive presentations from the heads of Orthopaedics' threebusinesses, Reconstructive Implants, Trauma and Clinical Therapies. Enquiries Liz Hewitt Tel: +44 (0) 20 7401 7646Group Director Corporate Affairs About us Smith & Nephew is a global medical technology business, specialising inOrthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephewis a global leader in arthroscopy and advanced wound management and is one ofthe fastest growing global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The company has over 8,500employees and operates in 33 countries around the world generating annual salesof £1.25 billion. Forward-Looking Statements This press release contains certain "forward-looking statements" within themeaning of the US Private Securities Litigation Reform Act of 1995. Inparticular, statements regarding expected revenue growth and operating marginsdiscussed under "Outlook" are forward-looking statements as are discussions ofour product pipeline. These statements, as well as the phrases "aim", "plan","intend", "anticipate", "well-placed", "believe", "estimate", "expect","target", "consider" and similar expressions, are generally intended to identifyforward-looking statements. Such forward-looking statements involve known andunknown risks, uncertainties and other important factors (including, but notlimited to, the outcome of litigation, claims and regulatory approvals) thatcould cause the actual results, performance or achievements of Smith & Nephew,or industry results, to differ materially from any future results, performanceor achievements expressed or implied by such forward-looking statements. Pleaserefer to the documents that Smith & Nephew has filed with the U.S. Securitiesand Exchange Commission under the U.S. Securities Exchange Act of 1934, asamended, including Smith & Nephew's most recent annual report on Form 20F, for adiscussion of certain of these factors. All forward-looking statements in this press release are based on informationavailable to Smith & Nephew as of the date hereof. All written or oralforward-looking statements attributable to Smith & Nephew or any person actingon behalf of Smith & Nephew are expressly qualified in their entirety by theforegoing. Smith & Nephew does not undertake any obligation to update or reviseany forward-looking statement contained herein to reflect any change in Smith &Nephew's expectation with regard thereto or any change in events, conditions orcircumstances on which any such statement is based. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew